Effects of Matuzumab in Combination With Pemetrexed for the Treatment of Advanced Lung Cancer

NCT00111839 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Lung Cancer
Non Small Cell Lung Carcinoma

Interventions

DRUG: Pemetrexed
DRUG: Matuzumab

Sponsor

EMD Serono